Task: Answer the multiple-choice question.
Question: Which compound exhibits a -11.873% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) CCOC(=O)Cc1cc(-c2ccc(OC)cc2)nc2ccc3ccccc3c12
b.) O=[N+]([O-])c1ccc(N2CCCC2)cc1N/N=C1\CN2CCC1CC2
Answer: b. O=[N+]([O-])c1ccc(N2CCCC2)cc1N/N=C1\CN2CCC1CC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=[N+]([O-])c1ccc(N2CCCC2)cc1N/N=C1\CN2CCC1CC2
O=[N+]([O-])c1ccc(N2CCCC2)cc1N/N=C1\CN2CCC1CC2
[2-[(2Z)-2-(1-azabicyclo[2.2.2]octan-3-ylidene)hydrazinyl]-4-pyrrolidin-1-ylphenyl]-oxido-oxoazanium